Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
about
Dolutegravir: clinical efficacy and role in HIV therapy.Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trialLong-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced patients with HIV type 1 infectionAntiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature.Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experience.Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus
P2860
Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Simplification to dual antiret ...... enced HIV-1-infected patients.
@en
Simplification to dual antiret ...... enced HIV-1-infected patients.
@nl
type
label
Simplification to dual antiret ...... enced HIV-1-infected patients.
@en
Simplification to dual antiret ...... enced HIV-1-infected patients.
@nl
prefLabel
Simplification to dual antiret ...... enced HIV-1-infected patients.
@en
Simplification to dual antiret ...... enced HIV-1-infected patients.
@nl
P2093
P50
P356
P1476
Simplification to dual antiret ...... enced HIV-1-infected patients.
@en
P2093
Albert Pahissa
Arkaitz Imaz
Daniel Podzamczer
Eva Van den Eynde
M Gracia Mateo
Manuel Crespo
Pere Domingo
Sara Villar
P304
P356
10.1093/JAC/DKS227
P407
P577
2012-06-22T00:00:00Z